-transparent.png){kind=logo}
Although endothelin-1 (ET-1) has been shown to have potent hypertrophic effects in cultured cardiac myocytes, there is no evidence that the production of ET-1 is altered in the hypertrophied heart in vivo. We investigated mRNA and peptide levels of ET-1 in the rat heart hypertrophied due to pressure or volume overload. One week after surgery of abdominal aortic banding (AB) or aortic valve regurgitation (AR; the aortic valve was destroyed by a polyethylene catheter), the rats were sacrificed. Control sham-operated rats were also studied (AB-sham and AR-sham). The left ventricular (LV) weight to body weight ratio was significantly higher in AB rats than in AB-sham rats. It was also significantly higher in AR rats than in AR-sham rats. Therefore, AB rats and AR rats developed LV hypertrophy due to pressure and volume overload, respectively. The expression of ET-1 mRNA in the LV was markedly higher in AB rats than in AB-sham rats. The peptide level of ET-1 was also significantly higher in the LV of AB rats than in that of AB-sham rats. However, the expression of ET-1 mRNA in the LV of AR rats was similar to that of AR-sham rats. The present findings suggest that the production of ET-1 in the heart differs between pressure and volume overload-induced hypertrophy in rats.
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
June 1996,
Journal of hypertension,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
September 1990,
Journal of molecular and cellular cardiology,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
February 1996,
Circulation research,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
June 1995,
Cardiovascular research,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
November 1969,
The American journal of the medical sciences,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
January 1987,
General pharmacology,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
October 2001,
Regulatory peptides,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
May 1990,
Journal of cardiovascular pharmacology,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
January 1989,
Journal of cardiovascular pharmacology,
S Sakai, and
R Yorikane, and
T Miyauchi, and
T Sakurai, and
Y Kasuya, and
I Yamaguchi, and
Y Sugishita, and
K Goto
July 1990,
Journal of cardiovascular pharmacology,
